Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
| Status: | Recruiting |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 10 - 50 |
| Updated: | 10/7/2018 |
| Start Date: | May 2015 |
| End Date: | September 2019 |
This study is a single center, randomized pilot study to evaluate the clinical effectiveness
of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
Inclusion Criteria:
- Confirmed diagnosis of CF
- Hospital admission for acute pulmonary exacerbation of CF (using Fuchs criteria 4/10)
- 10 years of age and older
- Subject is able to comply with the procedures scheduled in the protocol
- Signed informed consent form
Exclusion Criteria:
- Receipt of any aerosolized experimental or investigational drugs within 1 month of
enrollment
- Subject had ear, nose, and throat (ENT) surgery, nasal bleeding, or nasal polyps
within 6 months prior to study
- Subject is unlikely to comply with the procedures scheduled in the protocol
- Inability to give informed consent
- Subject requires supplemental oxygen
- History of obstructive sleep apnea
- History of pressure headaches requiring therapy within one month of enrollment
- Any other medical or psychological condition in which the study doctor(s) believe(s)
would inhibit the individual from being an appropriate study subject.
We found this trial at
1
site
Richmond, Virginia 23298
Principal Investigator: Bruce K Rubin, MD
Phone: 804-628-3921
Click here to add this to my saved trials
